Santen Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on November 30, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
November 07, 2023 at 01:00 am EST
Share
Santen Pharmaceutical Co., Ltd. announced dividend of JPY 16.00 per share for the second quarter ended September 30, 2023 against JPY 16.00 per share paid for the same period a year ago. Distribution of Dividends (Scheduled): November 30, 2023.
The company provided dividend guidance for the fiscal year ending March 31, 2024. For the year, The company expects dividend of JPY 16.00 per share against JPY 16.00 per share paid for the same period a year ago.
SANTEN PHARMACEUTICAL CO., LTD. is a Japan-based pharmaceutical company engaged in the research, development, manufacturing and sales of pharmaceutical products. The Company has medical pharmaceutical business, OTC drugs business, medical devices business and other businesses. The Company engages in manufacture, sale and clinical development of medical pharmaceutical products, the development, manufacturing and sales of medical equipment, as well as the cleaning business. The Company operates in Japan, Europe, Asia, North America markets.
Santen Pharmaceutical Co., Ltd. Announces Dividend for the Second Quarter Ended September 30, 2023, Payable on November 30, 2023; Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
SANTEN PHARMACEUTICAL CO., LTD. 
